Driven by biotechnological innovation, the company focuses on pharmaceutical R&D, production service outsourcing and microecological medicine. The company provides integrated services for large and medium-sized pharmaceutical companies, biotechnology companies, research institutes, etc. around the world, covering everything from early drug discovery to drug development and large-scale production stages, and standardization, precision, and human microecological health management of microecological medicine. Committed to becoming the world's leading CRO&CDMO partner and a full-life cycle integrated solution service provider for global pharmaceutical innovation. The company's main business includes the chemical business segment, pharmacodynamics business segment, and macromolecule business segment. Corporate honors: Won the “Top Ten Drug Innovation Service Agencies of the Year”, won the “2022 Top 20 Most Influential CXO Companies”, ranked in the “2021 Best Preclinical CRO/CDMO Companies” list, Shanghai Wisdom was selected as a TOP10 CRO company in the “2020 China Pharmaceutical Industry Top 100 Series List” for three consecutive years, and was awarded China's Top 10 Innovative CRO Companies, etc.